Opiate abuse and addiction risks are the greatest threat to our nation right now when it comes to drug and alcohol abuse and addiction.
Truthfully stated by the Centers for Disease Control and Prevention (CDC):
They had this to say:
Heroin addiction risks are almost as bad. For example, from the years of 2000 through 2013, the age-adjusted rate for overall drug-poisoning deaths involving heroin in one way or another, nearly quadrupled from 0.7 deaths per 100,000 in 2000 to 2.7 deaths per 100,000 in 2013. Most of the increase occurred after the year of 2010 when heroin and prescription opiates started being used in tandem. This means that heroin as a killer in the United States has now achieved the level of being an actual epidemic. Furthermore, the number of drug-poisoning deaths involving heroin was nearly four times higher for men (6,525 deaths) than women (1,732 deaths) in 2013, making it a much bigger problem for the men of the nation, not as much for the women of the nation.
Can Tests Predict Addiction Risks?
What if there was a way for doctors to better screen for addiction before it becomes a problem for their patients? What if doctors could screen their patients for risks of addiction before prescribing them drugs to ensure that their patients won’t end up becoming addicted to those drugs? A man by the name of Brian Meshkin, CEO of Proove Bioscience thinks that it is probable that he’s found something of a solution for all of us to use. He’s developed a product recently called Proove Opioid Risk, a straightforward and quick test that doctors give to patients that combine their genetic profile with the clinical observation that Proove says can predict a patient’s risk of becoming addicted to opioids with about ninety percent accuracy.
How does this test work through and is it legitimate? Apparently, a patient is asked six questions that were found to be highly predictive of future opioid addiction, such as if there is any personal history of substance use or a diagnosis of depression for one thing, or if they ever had any addicts in the family. Then, a DNA sample is collected from a cheek swab. The DNA is then sent to Proove where 12 different gene variants are analyzed for the potentiality of addiction. According to Meshkin, 12 genes are part of the brain’s mesolimbic system, the pathway of the brain associated with addiction. It’s often referred to as the reward circuit because it is activated when behaviors, like drug taking, are engaged upon.
Stopping Addiction by Any Means
This test is not necessarily foolproof by any means, but it could be the first of many improvements in our medical approach to trying to stop addiction from being such a problem. Addiction risks affect everybody, not just the addict.